Lymph Node Transplantation for Regenerative Cell Expansion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The shortage of available organs for transplant poses a significant medical, social, and economic challenge, and existing cell-based therapies often face obstacles such as inadequate environments in diseased organs and the lack of essential structures like a thymus.
Innovation Solution
The method involves transplanting non-lymphoid cells into lymphoid tissues, where they can proliferate, and subsequently introducing allograft tissue, leveraging the lymph node environment to promote the survival and expansion of healthy cells and tissues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cell-based therapy is directed at a diseased organ, then organ function can be restored, but the therapy becomes infeasible when the organ lacks appropriate environment or essential structures
Solution Approach 1:
The patent introduces the lymph node as an intermediary site that provides a permissive environment for transplanted cells. Instead of directly transplanting cells into a diseased organ that lacks appropriate environment, the lymph node serves as a mediator that supports cell survival, proliferation, and differentiation, thereby enabling cell-based therapy in organs that would otherwise be unsuitable for such treatment.
Solution Approach 2:
The lymph node is demonstrated to serve multiple functions: it acts as a transplantation site for various cell types (hepatocytes, pancreatic islets, thymic tissue), provides a permissive environment for cell survival and proliferation, and can be used across different disease states and organ systems. This multi-functionality makes the lymph node a universal platform for cell-based regenerative therapy.
2Reliability
If organs are transplanted to terminally ill patients, then organ function is restored, but the shortage of available organs creates a major medical and social challenge
Solution Approach 1:
The patent enables the patient's own lymph node to serve the dual purpose of maintaining its normal immune function while simultaneously acting as a transplantation site for regenerative cells. This self-service approach eliminates the need for separate transplantation sites and allows the body's existing structures to contribute to both immunity and tissue regeneration.
Solution Approach 2:
The patent segments the transplantation process from the traditional whole-organ transplant model. Instead of requiring complete organ replacement, the method uses cellular-level transplantation within the lymph node to achieve functional restoration, thereby reducing the dependency on scarce whole organs.
3Quantity of substance
If non-lymphoid cells are transplanted into lymphoid tissues, then cell proliferation and survival are promoted, but the lymph node environment must be optimized to support diverse tissue types
Solution Approach 1:
The patent utilizes changes in the lymph node microenvironment parameters (such as cytokine profiles, vascular architecture, and stromal cell composition) to create a permissive environment that supports diverse tissue types. By leveraging the natural plasticity and adaptability of the lymph node ecosystem, the method achieves high cell survival and expansion without requiring artificial modification of the lymph node structure.
Data Source
AI summary
The present invention relates to methods and compositions for transplanting non-lymphoid tissues into lymphoid organs. It may be used to cultivate organ tissues including for the purpose of supplementing or reconstituting organ function. Tissues that may be propagated in this manner include but are not limited to lung, kidney, thyroid, intestine, and brain.